Central retinal vein occlusion in a patient treated with antiandrogenic drug

Central retinal vein occlusion (CRVO) is usually seen in older adults and i s often associated with systemic vascular disease, this is much less eviden t in young people. A case report of a 28-year-old woman presented a central retinal vein occlu sion in her left eye. This young woman was treated with antiandrogenic drug . Investigations revealed an abnormality of the hemostasic system. The central retinal vein occlusion was resolved and the fundus assumed a no rmal appearance one-month after the primary episode. Retinal vascular occlusions with antiandrogenic drug may be due to three me chanisms: increased platelet cell aggregation, alteration of fibrinolytic s ystem and vascular endothelium hyperplasia.